Oral semaglutide (25 mg) is effective for weight loss in adults with overweight or obesity without diabetes, according to a study.

HealthDay News — During August 2021 to August 2023, only 36.4 percent of U.S. adults had no cardiovascular disease (CVD) risk factors, according to a September data brief published by the National ...

In a clinical practice guideline published in Practical Radiation Oncology, recommendations are presented for the use of postmastectomy radiation therapy (PMRT).

Multicomponent physical activity interventions were generally associated with positive outcomes among pediatric patients with obesity.

Guidance is presented for understanding the impact of potassium and phosphorus additives on people with chronic kidney disease (CKD) and managing their consumption.

Early rhythm control therapy in patients with atrial fibrillation with and without diabetes or obesity is safe and effective.

Insulin resistance was associated with adverse clinical outcomes among patients with PCOS and normal weight undergoing ...

GLP-1 RAs are not linked to an increased risk for serious GI or hepatobiliary outcomes, compared with other diabetes medications.

An association exists between higher night-to-night sleep duration variation and increased risk for major cardiovascular disease events.

Providing immediate bedside hepatitis C virus (HCV) consultation at discharge from labor and delivery for women with HCV-affected pregnancies is associated with higher rates of treatment completion ...

Population aging is the largest contributor to the increasing burden of musculoskeletal (MSK) disorders in about one-third of countries.

This patient perspective entails a first-hand experience of fatphobia and weight-inclusive health care in the clinical setting.